Precipio Receives Expected Delisting Determination from Nasdaq Staff and Will Request Nasdaq Hearing
27 March 2019 - 10:47PM
Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) today
announced that it has received the expected delisting determination
from Nasdaq Staff. The Company has subsequently filed a request for
a hearing before the Nasdaq Hearings Panel (the "Panel"), as
management believes that it has strong basis for requesting the
appeal. The process involves the Company requesting a compliance
hearing within 7 days from the receipt of the delisting
notification. Companies are typically scheduled for a hearing 30 to
45 days from the date of its request for a hearing, and the Hearing
Panel typically issues a decision within 30 days of the hearing.
As informed by Nasdaq, the delisting of the
company will be postponed pending a decision by the Hearing Panel -
meaning the company shall remain listed on Nasdaq until the hearing
takes place, and the Hearing Panel has issued a written
decision.
About PrecipioPrecipio has
built a platform designed to eradicate the problem of misdiagnosis
by harnessing the intellect, expertise and technology developed
within academic institutions and delivering quality diagnostic
information to physicians and their patients worldwide. Through its
collaborations with world-class academic institutions specializing
in cancer research, diagnostics and treatment such as the Yale
School of Medicine and Harvard’s Dana-Farber Cancer Institute,
Precipio offers a new standard of diagnostic accuracy enabling the
highest level of patient care. For more information, please visit
www.precipiodx.com.
Forward-Looking
StatementsCertain statements in this press release
constitute “forward-looking statements,” within the meaning of
federal securities laws, including potential market opportunity,
plans and prospects and other statements containing the words
“anticipate,” “intend,” “may,” “plan,” “predict,” “will,” “would,”
“could,” “should,” and similar expressions, constitute
forward-looking statements within the meaning of The Private
Securities Litigation Reform Act of 1995. The Company's actual
results could differ materially from those anticipated in these
forward-looking statements as a result of various factors. Factors
that could cause future results to materially differ from the
recent results or those projected in forward-looking statements
include the known risks, uncertainties and other factors described
in the Company’s definitive proxy statement filed on May 29, 2018,
the Company’s Quarterly Report on Form 10-Q for the quarter ended
September 30, 2018 and on the Annual Report on Form 10-K for the
year ended December 31, 2017 as well as the Company’s prior filings
and from time to time in the Company’s subsequent filings with the
Securities and Exchange Commission. Any change in such factors,
risks and uncertainties may cause the actual results, events and
performance to differ materially from those referred to in such
statements. All information in this press release is as of the date
of the release and the Company does not undertake any duty to
update this information, including any forward-looking statements,
unless required by law.
Precipio Inquiries:
investors@precipiodx.com
+1-203-787-7888
Precipio (NASDAQ:PRPO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Precipio (NASDAQ:PRPO)
Historical Stock Chart
From Apr 2023 to Apr 2024